SummerHaven Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$861K Sell
61,441
-8,011
-12% -$108K 0.53% 78
2025
Q4
$780K Hold
69,452
0.44% 138
2025
Q3
$803K Buy
+69,452
New +$813K 0.47% 132

Other funds holding AVNS

SummerHaven Investment Management's AVNS Position: Q1 2026 in Review

SummerHaven Investment Management reduced its Avanos Medical (AVNS) stake by 12% in Q1 2026, selling an estimated $108K and leaving 61,441 shares worth $861K. The position accounts for 0.53% of the portfolio, ranked #78.

SummerHaven Investment Management first reported a position in AVNS in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • SummerHaven Investment Management held 61,441 shares of Avanos Medical worth $861K as of Q1 2026.
  • SummerHaven Investment Management sold 8,011 Avanos Medical shares in Q1 2026, an estimated $108K.
  • Avanos Medical made up 0.53% of SummerHaven Investment Management's portfolio in Q1 2026, its #78 holding.
  • SummerHaven Investment Management first reported a position in Avanos Medical in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on SummerHaven Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.